Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) (344507)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Deadline: The deadline for this grant has passed

Grant amount: Up to US $2,200,000

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization. 

This broad PAR will support exploratory studies addressing mechanistic questions in HIV infection, replication, latency, and/or pathogenesis (including HAND) in the context of SUDs.

Applications may not request more than $350k direct costs for any single year of the R61 phase or more than $500k direct costs for any single year of the R33 phase. The maximum period of the combined R61/R33 is five years, with up to two years for the R61 Phase and three years for the R33 Phase. Funding of the R33 award will be determined by successful completion of the R61 scientific goals, as determined by NIH. 

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.